製薬大手の独ベーリンガー・インゲルハイムは18日、フランスに動物ワクチン工場を建設すると発表した。世界的に需要が拡大する口蹄疫と青舌病向けワクチンを生産する。
「ワクチン・バレー」として有名な仏南東部のローヌ・アルプ地域圏に施設面積1万5,000平方メートルの最新工場を建設する。投資額は2億ユーロ強。今秋に定礎式を行い2021年末に操業を開始する予定だ。新規雇用およそ100人を見込む。
製剤の配合と瓶詰は近隣のサン・プリエストにある拠点で行う。
Cookie | 期間 | 説明 |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |